paclitaxel has been researched along with Laryngeal Neoplasms in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (12.00) | 18.2507 |
| 2000's | 24 (48.00) | 29.6817 |
| 2010's | 17 (34.00) | 24.3611 |
| 2020's | 3 (6.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koo, P; Malin, M; Okereke, J | 1 |
| Cao, F; Fang, Q; Liu, X; Wu, D; Xu, P | 1 |
| Chen, B; Ding, Y; Fan, J; Gao, W; Nan, X; Wang, B; Wang, J; Wen, S; Wu, Y; Zhao, Q | 1 |
| Lu, CX; Sun, JH; Wu, CL | 1 |
| Huang, ZL; Jia, LF; Li, XM; Shan, S; Zhou, CY | 1 |
| Camille, N; Haddad, R; Limaye, S; Misiukiewicz, KJ; Posner, M; Tishler, R | 1 |
| Chen, XW; Dong, P; Jin, B; Sun, ZF; Wang, BX; Xie, J; Xu, CZ | 1 |
| Chen, XW; Dong, P; Li, DW; Wang, F; Xu, CZ; Zhou, L | 1 |
| Chen, J; Gao, JX; He, J; Ma, BJ; Wang, JY; Wei, XD | 1 |
| Dong, JR; Feng, HH; Guo, N; Li, Y; Liu, PD; Zhao, JP | 1 |
| Gao, C; Liu, M; Lu, W; Ren, H; Xie, C; Zhou, L | 1 |
| Chen, H; Cheng, L; Huang, JM; Tao, L; Tian, J; Xin, Y; Zhou, L | 1 |
| Deng, X; Li, S; Yang, X | 1 |
| Fang, JG; Feng, L; Lian, M; Liu, HG; Ma, HZ; Meng, LZ; Shi, Q | 1 |
| Luo, W; Zhou, L | 1 |
| Gagnon, PJ; Galderisi, C; Holland, JM; Page, BR | 1 |
| Budach, W; Dietz, A; Dreyhaupt, J; Eckel, H; Engenhardt-Cabillic, R; Flentje, M; Hagen, R; Hess, M; Hoppe, F; Jens, B; Kuhnt, T; Niewald, M; Pfreundner, L; Plinkert, P; Pritsch, M; Rudat, V; Schneider, P; Schröder, M; Schröder, U; Vanselow, B; Werner, JA; Zenner, HP | 1 |
| Dong, P; Jiang, AC; Li, L; Wang, H; Xu, C; Xu, W | 1 |
| Hagen, R; Hoppe, F; Pfreundner, L; Relic, A; Scheich, M; Stapf, J; Voelter, C | 1 |
| Ark, N; Diaz, EM; El-Naggar, AK; Garden, AS; Gillenwater, AM; Ginsberg, LE; Glisson, BS; Holsinger, FC; Khuri, FR; Ki Hong, W; Kies, MS; Lee, JJ; Lewin, JS; Lin, HY; Shin, DM | 1 |
| Gruensfelder, P; Hagen, R; Polednik, C; Roller, J; Schmidt, M | 1 |
| Chen, A; Davis, LW; Edelman, S; Gaultney, J; Grist, W; Khuri, FR; Saba, NF; Shin, DM; Tighiouart, M | 1 |
| Li, HZ; Li, JF; Liu, WW; Lu, SM; Wang, HB; Xu, W; Yu, L | 1 |
| Li, HZ; Li, JF; Liu, WW; Lu, SM; Tian, JJ; Wang, HB; Xu, W; Yu, L | 1 |
| Fietkau, R; Iro, H; Klautke, G; Kuwert, T; Lell, M; Linke, R; Semrau, S; Uder, M; Waldfahrer, F | 1 |
| Jin, CS; Liu, Y; Wen, LJ; Yang, JP; Yu, D; Zhong, W | 1 |
| Cullen, KJ; Goloubeva, O; Kwok, Y; Ord, R; Parekh, A; Strome, S; Suntharalingam, M; Taylor, R; Wolf, J; Zimrin, A | 1 |
| Ahmed, N; Hegde, U; Jabbour, N; Usmani, S | 1 |
| Blair, EA; Cohen, EEW; Haraf, DJ; List, M; Mouw, KW; Salama, JK; Solanki, AA; Stenson, KM; Vokes, EE; Witt, ME | 1 |
| Dong, Y; Ni, G; Wang, J | 1 |
| Barros, AP; Carrara-de Angelis, E; Feher, O; Kowalski, LP; Nishimoto, IN | 1 |
| Bratengeier, K; Flentje, M; Hagen, R; Helms, J; Hoppe, F; Pfreundner, L; Preisler, V; Willner, J | 1 |
| Chen, W; Cui, P; Jiang, X; Zhang, D; Zhang, Z | 1 |
| Becker, A; Bloching, M; Dunst, J; Hänsgen, G; Kuhnt, T; Lotterer, E; Passmann, M; Pelz, T; Pigorsch, S | 1 |
| Liu, J; Wang, J | 1 |
| Carvalho, AL; Feher, O; Gomez, MV; Kowalski, LP; Liberman, PH; Pellizzon, AC; Schultz, C; Testa, JR | 1 |
| Kong, W; Zhang, S | 1 |
| Burkey, B; Cmelak, AJ; Douglas, S; Murphy, BA; Netterville, J; Shyr, Y | 1 |
| Hu, T; Xie, M; Yao, M; Zhou, L | 1 |
| Emel'yanov, MO; Korystov, YN; Korystova, AF; Kublik, LN; Shaposhnikova, VV | 1 |
| Cannon, M; Cmelak, AJ; Forastiere, AA; Gillison, M; Goldwasser, MA; Li, S; Murphy, B; Pinto, H; Rosenthal, DI | 1 |
| Dong, P; Jiang, AC; Li, L; Wan, Y; Yu, ZW | 1 |
| Alvarez Marcos, CA; de Bock, GH; Gibcus, JH; Hermsen, MA; Kluin, PM; Kok, K; Langendijk, JA; Mastik, MF; Menkema, L; Schuuring, E; Takes, RP; van den Brekel, MW; van der Laan, BF; van der Wal, JE; van Velthuysen, ML | 1 |
| Tian, J; Xie, M; Zhang, M; Zhou, L | 1 |
| Cohen, EE; Haraf, DJ; Knab, BR; Salama, JK; Solanki, A; Stenson, KM; Vokes, EE; Witt, ME | 1 |
| Elomaa, L; Grénman, R; Joensuu, H; Klemi, P; Kulmala, J | 1 |
| Elomaa, L; Grenman, R; Joensuu, H; Martikainen, P; Pulkkinen, JO; Servomaa, K | 1 |
| Ingram, ML; Redpath, JL | 1 |
| Ciesielski-Carlucci, C; Jacobs, C; Leong, P | 1 |
| Friedl, R; Hagen, R; Hoppe, F; Pfreundner, L; Preisler, VK; Schindler, D; Stopper, H | 1 |
1 review(s) available for paclitaxel and Laryngeal Neoplasms
| Article | Year |
|---|---|
Case report of anaphylaxis from cisplatin/paclitaxel and a review of their hypersensitivity reaction profiles.
Topics: Aged; Anaphylaxis; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Hypersensitivity; Fatal Outcome; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Paclitaxel; Respiratory Insufficiency; Vocal Cords | 1997 |
6 trial(s) available for paclitaxel and Laryngeal Neoplasms
| Article | Year |
|---|---|
Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Treatment Outcome | 2009 |
Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Drug Administration Schedule; ErbB Receptors; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Prospective Studies; Remission Induction; Squamous Cell Carcinoma of Head and Neck | 2012 |
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Female; Fluorouracil; Humans; Hydroxyurea; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Paclitaxel; Quality of Life; Risk Factors; Time Factors; Treatment Outcome | 2012 |
Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Cohort Studies; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Metastasis; Oropharyngeal Neoplasms; Paclitaxel; Radiotherapy Dosage; Stomatitis; Survival Analysis; Time Factors | 2003 |
Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Paclitaxel; Survival Rate; Tongue Neoplasms | 2007 |
Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Deglutition Disorders; Female; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Pharyngectomy; Platinum; Radiotherapy, Adjuvant; Recovery of Function; Salvage Therapy; Speech Disorders; Taxoids; Treatment Outcome | 2007 |
43 other study(ies) available for paclitaxel and Laryngeal Neoplasms
| Article | Year |
|---|---|
A 31-Year-Old Pregnant Woman With Asthma, Presenting With Worsening Dyspnea, Wheeze, and Hoarseness.
Topics: Adult; Antineoplastic Agents; Asthma; Carboplatin; Cesarean Section; Cyclin-Dependent Kinase Inhibitor p16; Deglutition Disorders; Diagnosis, Differential; Female; Hoarseness; Humans; Laryngeal Neoplasms; Laryngoscopy; Paclitaxel; Papillomavirus Infections; Pregnancy; Pregnancy Complications, Neoplastic; Radiotherapy; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Head and Neck Neoplasms; Humans; Immune Checkpoint Inhibitors; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Quality of Life; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Topics: Animals; Antigens, Ly; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Drug Resistance, Neoplasm; Female; Fluorouracil; GPI-Linked Proteins; Hep G2 Cells; Humans; Laryngeal Neoplasms; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Paclitaxel; Transcriptome | 2020 |
[Apoptosis mechanism of taxol combined with resveratrol on human laryngeal carcinoma Hep-2 cells].
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 8; Cell Line, Tumor; Humans; Laryngeal Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes | 2016 |
[Metformin's effect on 5-fluorouracil,cisplatin,paclitaxel in laryngocarcinoma Hep-2 cells].
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Fluorouracil; Humans; Hypoglycemic Agents; Laryngeal Neoplasms; Metformin; Paclitaxel | 2017 |
Organ preservation for adenoid cystic carcinoma of the larynx.
Topics: Aged; Carboplatin; Carcinoma, Adenoid Cystic; Chemoradiotherapy; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Organ Sparing Treatments; Paclitaxel | 2013 |
Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line.
Topics: Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Laryngeal Neoplasms; MicroRNAs; Oligonucleotide Array Sequence Analysis; Paclitaxel; Real-Time Polymerase Chain Reaction; Time Factors | 2013 |
Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1α.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Proliferation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Laryngeal Neoplasms; Paclitaxel; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured | 2013 |
[Investigation on biological characteristics of CD133+ cancer stem cells in human laryngeal carcinoma Hep-2 cell line].
Topics: AC133 Antigen; Antigens, CD; Cell Line, Tumor; Flow Cytometry; Glycoproteins; Hep G2 Cells; Humans; Laryngeal Neoplasms; Neoplastic Stem Cells; Paclitaxel; Peptides | 2013 |
Inhibition of nemo-like kinase increases taxol sensitivity in laryngeal cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Intracellular Signaling Peptides and Proteins; Laryngeal Neoplasms; Paclitaxel; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured | 2013 |
EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Liberation; ErbB Receptors; Humans; Laryngeal Neoplasms; Micelles; Microscopy, Electron, Transmission; Paclitaxel; Particle Size; Peptides; Phosphatidylethanolamines; Polyethylene Glycols; Technology, Pharmaceutical | 2015 |
Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Drug Delivery Systems; Female; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Paclitaxel; RNA, Long Noncoding; Squamous Cell Carcinoma of Head and Neck | 2014 |
[The vitro research of effects of Beclin1 on paclitaxel-sensitivity in laryngeal carcinoma cell Hep-2].
Topics: Apoptosis; Apoptosis Regulatory Proteins; Beclin-1; Cell Line, Tumor; Cell Proliferation; Humans; Laryngeal Neoplasms; Larynx; Membrane Proteins; Paclitaxel; Phosphatidylinositol 3-Kinases | 2015 |
[A preliminary analysis on potentially targeted genes of induced chemotherapy in supraglottic laryngeal squamous cell carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Down-Regulation; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression; Gene Expression Profiling; Genes, p53; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Paclitaxel; Proto-Oncogene Proteins p21(ras); Signal Transduction | 2016 |
Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation.
Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Colorimetry; Flow Cytometry; Hep G2 Cells; Humans; Laryngeal Neoplasms; Liposomes; Microbubbles; Molecular Targeted Therapy; Paclitaxel; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2017 |
Angiosarcoma developing after curative induction chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the larynx.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Squamous Cell; Follow-Up Studies; Hemangiosarcoma; Humans; Immunohistochemistry; Laryngeal Neoplasms; Male; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Radiotherapy, High-Energy; Remission Induction; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2009 |
MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Laryngeal Neoplasms; Neoplasm Invasiveness; Paclitaxel; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Female; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Salvage Therapy; Taxoids; Treatment Outcome | 2009 |
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ifosfamide; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Survival Rate; Treatment Outcome; Young Adult | 2009 |
The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Fluorescent Antibody Technique; Humans; Keratinocytes; Laryngeal Neoplasms; Neoplasms, Squamous Cell; Paclitaxel; Tubulin | 2009 |
Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis.
Topics: Adult; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Analysis; Treatment Outcome | 2009 |
Alteration in TWIST expression: possible role in paclitaxel-induced apoptosis in human laryngeal carcinoma Hep-2 cell line.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma; Cell Line, Tumor; Flow Cytometry; Gene Expression; Humans; Laryngeal Neoplasms; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Twist-Related Protein 1 | 2009 |
[Role of TWIST in the apoptosis of Hep-2 cells induced by paclitaxel].
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; Laryngeal Neoplasms; Nuclear Proteins; Paclitaxel; RNA, Messenger; Twist-Related Protein 1 | 2009 |
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early r
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Laryngeal Neoplasms; Leukopenia; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Opportunistic Infections; Paclitaxel; Positron-Emission Tomography; Radiodermatitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Salvage Therapy; Taxoids; Thrombocytopenia; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 2011 |
Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
Topics: AC133 Antigen; Antigens, CD; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blotting, Western; Carcinoma; Cell Line, Tumor; Cisplatin; Flow Cytometry; Fluorouracil; Glycoproteins; Humans; Laryngeal Neoplasms; Neoplasm Proteins; Neoplastic Stem Cells; Paclitaxel; Peptides; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Acute psychosis after paclitaxel infusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Follow-Up Studies; Humans; Infusion Pumps; Laryngeal Neoplasms; Male; Paclitaxel; Parkinson Disease; Psychotic Disorders; Risk Factors | 2011 |
[Study on the effects of taxol on Hep-2 cell lines in larynx carcinoma].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Dose-Response Relationship, Drug; Humans; Laryngeal Neoplasms; Paclitaxel; Tumor Cells, Cultured | 1999 |
Voice and swallowing in patients enrolled in a larynx preservation trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Deglutition; Female; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Paclitaxel; Treatment Outcome; Voice; Voice Disorders | 2003 |
Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Female; Humans; Hypopharyngeal Neoplasms; Imaging, Three-Dimensional; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Prospective Studies; Radiation Injuries; Tomography, X-Ray Computed | 2003 |
[Inhibition of human laryngeal cancer Hep-2 cells by taxol].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Laryngeal Neoplasms; Paclitaxel | 2003 |
[Experimental study of taxol combining accelerated radiation on laryngeal carcinoma cells].
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line, Tumor; Combined Modality Therapy; Humans; Laryngeal Neoplasms; Paclitaxel; Particle Accelerators; Radiation-Sensitizing Agents | 2002 |
Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Audiometry, Pure-Tone; Auditory Threshold; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Hearing Loss, Sensorineural; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiotherapy; Radiotherapy Dosage | 2004 |
[Chemotherapy guidance of the drug sensitivity test in vitro in human laryngeal squamous cell carcinoma].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Laryngeal Neoplasms; Paclitaxel | 2006 |
Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Capillaries; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Fibroblast Growth Factor 2; Immunohistochemistry; Lactic Acid; Laryngeal Neoplasms; Mice; Microspheres; Neoplasm Transplantation; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Transplantation, Heterologous; Vascular Endothelial Growth Factor A | 2007 |
Modification of multidrug resistance of tumor cells by ionizing radiation.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Count; Cell Line, Tumor; Combined Modality Therapy; Cyclosporine; Daunorubicin; Dose-Response Relationship, Radiation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Laryngeal Neoplasms; Paclitaxel; Radiation, Ionizing; Reactive Oxygen Species; Rhodamine 123; Time Factors; Vincristine | 2008 |
The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Cell Cycle; Cell Line, Tumor; Cisplatin; Deoxycytidine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Dyes; Fluorouracil; Gemcitabine; Humans; Laryngeal Neoplasms; Multidrug Resistance-Associated Proteins; Paclitaxel; Rhodamine 123 | 2007 |
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cell Cycle; Chromosome Aberrations; Chromosome Mapping; Chromosomes, Human, Pair 11; Fas-Associated Death Domain Protein; Gene Expression Profiling; Humans; Laryngeal Neoplasms; Nucleic Acid Hybridization; Paclitaxel; Pharyngeal Neoplasms; Phosphorylation; Time Factors | 2007 |
[Synergistic interactions of TRAIL and paclitaxel on the laryngeal squamous carcinoma cell line in vitro].
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Synergism; Humans; Laryngeal Neoplasms; Paclitaxel; TNF-Related Apoptosis-Inducing Ligand | 2007 |
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Hydroxyurea; Immunohistochemistry; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Organ Preservation; Paclitaxel; Probability; Quality of Life; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2008 |
Squamous cell carcinoma is highly sensitive to taxol, a possible new radiation sensitizer.
Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Cells, Cultured; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Flow Cytometry; Growth Inhibitors; Humans; In Vitro Techniques; Laryngeal Neoplasms; Larynx; Male; Paclitaxel | 1995 |
Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; DNA Damage; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Paclitaxel; Tumor Cells, Cultured; Video Recording | 1996 |
Subadditive interaction of radiation and Taxol in vitro.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Survival; Drug Administration Schedule; Drug Screening Assays, Antitumor; G2 Phase; Humans; Laryngeal Neoplasms; Paclitaxel; Radiation Tolerance; Radiotherapy Dosage; Tumor Cells, Cultured | 1997 |
Cytotoxic and genotoxic effects of paclitaxel (Taxol) and radiation in a squamous cell carcinoma cell line of the larynx.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Cycle; Flow Cytometry; Humans; Laryngeal Neoplasms; Paclitaxel; Radiation Dosage; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1998 |